Summary & Overview
HCPCS Level II J7609: Albuterol Inhalation Solution, Compounded, Unit Dose, 1 mg
HCPCS Level II code J7609 denotes a compounded albuterol inhalation solution, unit dose 1 mg, supplied for administration through durable medical equipment. This code captures dispensed, single-dose nebulized bronchodilator therapy commonly used for acute bronchospasm and maintenance inhalation therapy when a compounded formulation is required. Nationally, accurate coding for compounded inhalation solutions affects claims processing, DME-associated billing, and clinical documentation for respiratory care.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage considerations, allowable coding contexts, and typical sites of service for DME-delivered nebulized medication.
Readers will find a concise breakdown of the clinical context for using a compounded albuterol nebulizer solution, operational considerations for DME administration, and the policy and billing topics that commonly arise with J7609. The report provides benchmarking insights, common modifier usage (listed separately), and guidance on documentation elements that support medical necessity. Data not available in the input are explicitly noted where applicable.
Billing Code Overview
HCPCS Level II code J7609 describes albuterol inhalation solution, compounded product, administered through durable medical equipment (DME), unit dose, 1 mg. This code represents a compounded nebulized bronchodilator preparation of albuterol provided in single unit doses for inhalation therapy.
Service Type: Nebulized inhalation medication administration (bronchodilator therapy)
Typical Site of Service: Home or outpatient settings where durable medical equipment (nebulizer) is used, including home health, outpatient infusion centers, and other ambulatory care locations where DME is utilized for inhalation therapy.
Clinical & Coding Specifications
Clinical Context
A 7-year-old child with moderate persistent asthma presents to a pediatric pulmonary clinic for increased wheeze and shortness of breath despite home albuterol inhaler use. The clinician elects to administer a nebulized dose of compounded albuterol inhalation solution delivered via the facility’s DME nebulizer in a unit-dose syringe. The medication corresponds to J7609 (albuterol, inhalation solution, compounded product, administered through DME, unit dose, 1 mg). The clinical workflow includes medication preparation by the pharmacy (compounding a sterile unit-dose), verification of dose and patient identity, delivery through the nebulizer by respiratory therapy or nursing, monitoring of vital signs and respiratory status during administration, documentation of medication lot and unit-dose identifier, and post-treatment assessment for bronchodilator response. Billing is submitted under the outpatient or ambulatory DME administration setting; modifiers may be appended to reflect unusual circumstances such as an unrelated procedure, patient condition, or altered service level.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Used when no special circumstances apply to the billed service |